Completed PHASE3 INTERVENTIONAL 2-arm NCT02694146

Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis (COX)

Clinical Trial Randomized, Double-blind Controlled, Phase III, to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis

Sponsor: Fundación Pública Andaluza Progreso y Salud

Conditions Coxarthrosis

Interventions Hylan G-F 20 Platelet rich plasma

Updated 9 times since 2017 Last updated: Feb 21, 2019 Started: Mar 31, 2016 Primary completion: May 31, 2018 Completion: May 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02694146, this PHASE3 trial focuses on Coxarthrosis and remains completed. Sponsored by Fundación Pública Andaluza Progreso y Salud, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Feb 2020 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Mar 2019 — Feb 2020 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE3
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Oct 2017 [monthly]

Recruiting PHASE3

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación Pública Andaluza Progreso y Salud

Data source: Andalusian Network for Design and Translation of Advanced Therapies

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pontevedra, Spain
• Seville, Spain